Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 450 participants.
Also called NCT05051033
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 450 participants
- Registry
-
NCT05051033
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, Germany, Spain, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05051033. Randomized; no masking; primary purpose treatment. Start 2022-02-21 (actual); primary completion 2029-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
- Acronym
- PRIMARY
- Condition
- Mitral Valve Regurgitation
- Intervention (Procedure)
- Mitral valve repair
- Intervention (Device)
- Transcatheter edge-to-edge repair
- Lead sponsor
- Annetine Gelijns
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct05051033- Content hash
f9cc220be1c2e91eb26ab0923e42388a0a1265a9f42a0809f8757af1e79c1fc0